Sera Prognostics(SERA.US)

Last Updated 19:00:00 ET
longbridge loading

Sera Prognostics | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 14 K

Earnings Watch·
US
SERA
+0.86%
Earnings Watch·
US
SERA
+0.86%

SERA Q1'26 Earnings: EPS estimate is (0.17) USD

TradingView·
US
SERA
+0.86%
TradingView·
US
SERA
+0.86%

SERA PROGNOSTICS ANNOUNCES CONFERENCE CALL AND WEBCAST OF FIRST QUARTER FISCAL YEAR 2026 FINANCIAL RESULTS ON MAY 6, 2026 | SERA Stock News

StockTitan·
US
SERA
+0.86%
US
FBT
+1.23%
US
IBB
+1.77%
StockTitan·
US
SERA
+0.86%
US
FBT
+1.23%
US
IBB
+1.77%

Non-invasive diagnostics in endometriosis: at the cusp of a turning point

Pharmaceutical Technology·
SH
CS精准医
+0.59%
US
SERA
+0.86%
SZ
003008
-1.01%
Pharmaceutical Technology·
SH
CS精准医
+0.59%
US
SERA
+0.86%
SZ
003008
-1.01%

Seres Group Unveils Audited 2025 Results and Proposes Robust Cash Dividend

Tip Ranks·
SH
588860
+0.29%
SH
512290
-0.11%
SH
560600
0.00%
Tip Ranks·
SH
588860
+0.29%
SH
512290
-0.11%
SH
560600
0.00%

TD Cowen Sticks to Its Buy Rating for Sera Prognostics (SERA)

Tip Ranks·
US
LABD
-9.96%
US
XBI
+3.33%
US
IHI
+0.46%
Tip Ranks·
US
LABD
-9.96%
US
XBI
+3.33%
US
IHI
+0.46%

Sera Prognostics (NASDAQ:SERA) Releases Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Market Beat·
US
SERA
+0.86%
US
LABU
+10.12%
US
PBE
+0.89%
Market Beat·
US
SERA
+0.86%
US
LABU
+10.12%
US
PBE
+0.89%
© 2026 Longbridge｜Disclaimer